Sitemap
Sitemap- Drugs
- Introduction
- New Drug Application (NDA)
- Application of Clinical Protocol Review
- Bridging Study Evaluation(BSE)
- Active Pharmaceutical Ingredient (API)
- Abbreviated New Drug Application (ANDA)
- Clinical trials of pharmaceutical products
- New Drug
- Generic Drug
- Drug Substances
- Clinical Trials
- Instruction Drugs and Over-the-Counter Drugs (OTC)
- Medical Devices
- Introduction
- Medical Devices
- Clinical investigation
- Education & training
- Technical Dossier Evaluation
- Regulatory Consultations
- Databases
- Related links
- Consultation Services
- Introduction
- Drugs
- Medical Devices
- Health Technology Assessment
- Health Technology Assessment
- Introduction
- Milestones in HTA History
- Assessment Services
- Achievement presentation
- Planning of the NIHTA
- International
- Introduction
- International Participation
- Cross-Strait Communication and Cooperation
- Major Achievements
Cooperation
- Relevant laws and regulations
- Drugs
- Medical Devices
- Consultation Services
- Health Technology Assessment
- International Cooperation
- FAQ
- Drugs
- Medical Devices
- Consultation Services
- Health Technology Assessment
- International Cooperation
- Related Link
- Government
- Non-Governmental
- Internal site search
- Internal site search
Address：3F No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C
Tel：+886-2-8170-6000 
Fax：+886-2-8170-6001、+886-2-8170-6002